Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer [Phase 1]

View source ↗

Summary

This clinical trial update describes an early-phase study of MRI-guided brachytherapy for HPV-associated cervical and vaginal cancers, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Human Papillomavirus-Related Carcinoma, Human Papillomavirus-Related Cervical Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING